Docusign (NASDAQ:DOCU) Price Target Lowered to $54.00 at UBS Group

Docusign (NASDAQ:DOCU) had its price target decreased by UBS Group from $75.00 to $54.00 in a research report report published on Wednesday,Benzinga reports. UBS Group currently has a neutral rating on the stock.

Several other research analysts have also weighed in on the stock. HSBC set a $53.00 target price on shares of Docusign in a research report on Friday, February 13th. Citigroup reissued a “market outperform” rating on shares of Docusign in a research note on Monday, March 2nd. Weiss Ratings restated a “hold (c)” rating on shares of Docusign in a report on Wednesday, January 21st. Cantor Fitzgerald reaffirmed an “outperform” rating on shares of Docusign in a research note on Wednesday, December 17th. Finally, Wells Fargo & Company reduced their price objective on Docusign from $75.00 to $60.00 and set an “equal weight” rating for the company in a report on Wednesday. Five research analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the stock. According to MarketBeat, Docusign currently has an average rating of “Hold” and an average price target of $66.67.

Docusign Stock Performance

Shares of NASDAQ DOCU opened at $48.90 on Wednesday. Docusign has a one year low of $40.16 and a one year high of $94.67. The firm has a market capitalization of $9.79 billion, a P/E ratio of 33.04, a PEG ratio of 2.07 and a beta of 1.03. The company’s fifty day moving average is $50.69 and its two-hundred day moving average is $64.35.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.06. Docusign had a net margin of 9.60% and a return on equity of 16.70%. The business had revenue of $836.86 million during the quarter, compared to the consensus estimate of $828.23 million. During the same quarter last year, the firm posted $0.86 EPS. The business’s revenue was up 7.8% compared to the same quarter last year. On average, sell-side analysts forecast that Docusign will post 1.17 earnings per share for the current fiscal year.

Docusign announced that its Board of Directors has initiated a stock repurchase plan on Tuesday, March 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 21% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s board of directors believes its shares are undervalued.

Insider Buying and Selling at Docusign

In other news, insider James P. Shaughnessy sold 12,000 shares of the stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $67.03, for a total value of $804,360.00. Following the sale, the insider directly owned 54,550 shares in the company, valued at $3,656,486.50. This represents a 18.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CRO Paula Hansen sold 6,000 shares of the firm’s stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $67.05, for a total transaction of $402,300.00. Following the transaction, the executive directly owned 68,970 shares of the company’s stock, valued at approximately $4,624,438.50. This trade represents a 8.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 51,477 shares of company stock valued at $3,521,607 over the last three months. Company insiders own 1.01% of the company’s stock.

Hedge Funds Weigh In On Docusign

A number of institutional investors have recently made changes to their positions in DOCU. Central Pacific Bank Trust Division purchased a new stake in shares of Docusign in the fourth quarter valued at $25,000. Modus Advisors LLC acquired a new stake in shares of Docusign during the fourth quarter valued at $27,000. Torren Management LLC purchased a new stake in Docusign during the 4th quarter worth about $28,000. True Wealth Design LLC increased its position in Docusign by 105.2% during the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after purchasing an additional 222 shares in the last quarter. Finally, Aventura Private Wealth LLC acquired a new position in Docusign in the 4th quarter valued at about $30,000. 77.64% of the stock is owned by institutional investors and hedge funds.

More Docusign News

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q4 results and FY27 outlook beat estimates — DocuSign reported adjusted EPS of $1.01 and revenue of $836.9M, topping Street forecasts and signaling continued subscription growth and momentum into fiscal 2027. Docusign’s Q4 Earnings and Revenues Surpass Estimates, Increase Y/Y
• Positive Sentiment: Share‑repurchase boost — Management authorized a $2.0 billion increase to the buyback program, a direct capital‑return action that supports EPS and signals confidence from the board. PR Newswire: Share Repurchase Increase
• Positive Sentiment: Product traction in IAM and AI — Management highlighted strong IAM ARR (> $350M after 18 months) and plans to grow IAM share and AI partnerships, supporting secular expansion beyond e‑signatures. Seeking Alpha: IAM ARR and AI Partnerships
• Neutral Sentiment: Analysts and investors want higher top‑line acceleration — Coverage notes that while results showed traction, many want to see sustained >10% revenue growth before committing, leaving some investors on the sidelines. MSN: Analysts Wait for 10%+ Revenue Growth
• Neutral Sentiment: Some buy ratings remain — BTIG reaffirmed a buy with a $70 target, showing pockets of analyst optimism despite broad caution. Benzinga: BTIG Reaffirms Buy
• Negative Sentiment: Broad downward revisions to price targets — Multiple firms (Citigroup, Morgan Stanley, JPMorgan, UBS, Wells Fargo, RBC, Piper Sandler, Baird, others) cut targets after the print, reflecting concerns about growth runway and execution; that pressure caps upside even with the beat. Blockonomi: Analyst Targets Slashed TickerReport: Citigroup Cut
• Negative Sentiment: Valuation and growth trade‑offs highlighted — Analysts trimmed fair‑value estimates and flagged pricing/AI competition risks, underscoring why some investors remain cautious despite product progress. Yahoo Finance: Valuation and AI Risks

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.